1. Obesity and cardiovascular disease: a scientific statement from the American heart association. Circulation;Powell-Wiley,2021
2. Glucagon-like peptide-1 analogues: an overview;Gupta,2013
3. FDA approves once-weekly semaglutide for weight loss;Schaffer,2021
4. Anti-obesity medications and investigational agents: an obesity medicine association (OMA) clinical Practice statement (CPS) 2022;Bays;Obesity Pillars,2022